Cheap Entry into a High-Reward Gamma-Delta Cell Bet: ACET Trade Idea
Adicet Bio (ACET) offers a low-cap, high-volatility way to play off-the-shelf gamma delta T-cell therapies. At a market cap ~ $77M and a current price of $8.20, the stock looks inexpensive on book value and enterprise value, but the path to upside hinges on clinical readouts and capital markets activity. This trade lays out an actionable long with …